Biontech Se Stock Price History
BNTX Stock | USD 118.39 2.33 1.93% |
Below is the normalized historical share price chart for BioNTech SE extending back to October 10, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of BioNTech stands at 118.39, as last reported on the 30th of November, with the highest price reaching 120.48 and the lowest price hitting 117.79 during the day.
If you're considering investing in BioNTech Stock, it is important to understand the factors that can impact its price. BioNTech appears to be very steady, given 3 months investment horizon. BioNTech SE secures Sharpe Ratio (or Efficiency) of 0.14, which signifies that the company had a 0.14% return per unit of risk over the last 3 months. By analyzing BioNTech's technical indicators, you can evaluate if the expected return of 0.54% is justified by implied risk. Please makes use of BioNTech's Downside Deviation of 2.67, mean deviation of 2.38, and Risk Adjusted Performance of 0.1137 to double-check if our risk estimates are consistent with your expectations.
At this time, BioNTech's Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 24.2 B in 2024, whereas Common Stock Total Equity is likely to drop slightly above 185.2 M in 2024. . At this time, BioNTech's Price Book Value Ratio is fairly stable compared to the past year. Price To Operating Cash Flows Ratio is likely to rise to 4.53 in 2024, whereas Price To Sales Ratio is likely to drop 5.77 in 2024. BioNTech Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 10th of October 2019 | 200 Day MA 96.2641 | 50 Day MA 113.523 | Beta 0.259 |
BioNTech |
Sharpe Ratio = 0.1426
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | BNTX | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
3.78 actual daily | 33 67% of assets are more volatile |
Expected Return
0.54 actual daily | 10 90% of assets have higher returns |
Risk-Adjusted Return
0.14 actual daily | 11 89% of assets perform better |
Based on monthly moving average BioNTech is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BioNTech by adding it to a well-diversified portfolio.
Price Book 1.4059 | Enterprise Value Ebitda 110.8146 | Price Sales 9.3361 | Shares Float 91.6 M | Wall Street Target Price 129.4987 |
BioNTech Stock Price History Chart
There are several ways to analyze BioNTech Stock price data. The simplest method is using a basic BioNTech candlestick price chart, which shows BioNTech price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | September 17, 2024 | 124.71 |
Lowest Price | September 6, 2024 | 89.94 |
BioNTech November 30, 2024 Stock Price Synopsis
Various analyses of BioNTech's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell BioNTech Stock. It can be used to describe the percentage change in the price of BioNTech from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of BioNTech Stock.BioNTech Price Daily Balance Of Power | (0.87) | |
BioNTech Price Action Indicator | (1.91) | |
BioNTech Accumulation Distribution | 11,585 | |
BioNTech Price Rate Of Daily Change | 0.98 |
BioNTech November 30, 2024 Stock Price Analysis
BioNTech Stock Price History Data
The price series of BioNTech for the period between Sun, Sep 1, 2024 and Sat, Nov 30, 2024 has a statistical range of 37.11 with a coefficient of variation of 8.9. The prices are distributed with arithmetic mean of 110.73. The median price for the last 90 days is 112.51. The company issued dividends on 2022-06-02.Open | High | Low | Close | Volume | ||
11/29/2024 | 120.40 | 120.48 | 117.79 | 118.39 | 518,891 | |
11/27/2024 | 119.00 | 121.51 | 118.60 | 120.72 | 604,788 | |
11/26/2024 | 119.73 | 121.80 | 117.00 | 118.54 | 771,422 | |
11/25/2024 | 114.10 | 121.11 | 113.44 | 120.76 | 1,972,551 | |
11/22/2024 | 107.87 | 114.32 | 107.41 | 113.13 | 1,185,879 | |
11/21/2024 | 102.38 | 108.74 | 101.26 | 108.23 | 1,033,240 | |
11/20/2024 | 105.80 | 105.82 | 101.02 | 102.14 | 1,128,255 | |
11/19/2024 | 102.78 | 108.01 | 102.67 | 106.40 | 1,177,718 | |
11/18/2024 | 99.30 | 102.48 | 98.25 | 101.87 | 1,286,656 | |
11/15/2024 | 99.89 | 101.65 | 94.31 | 99.72 | 3,376,703 | |
11/14/2024 | 112.90 | 115.93 | 102.14 | 103.56 | 1,699,733 | |
11/13/2024 | 105.79 | 113.20 | 105.79 | 111.48 | 1,293,163 | |
11/12/2024 | 107.42 | 108.90 | 105.62 | 106.32 | 603,659 | |
11/11/2024 | 110.45 | 110.96 | 107.54 | 108.73 | 1,408,645 | |
11/08/2024 | 112.83 | 115.32 | 110.01 | 110.64 | 1,237,358 | |
11/07/2024 | 107.66 | 110.48 | 106.70 | 107.88 | 578,545 | |
11/06/2024 | 107.52 | 109.29 | 102.52 | 106.64 | 1,218,060 | |
11/05/2024 | 108.85 | 111.25 | 108.35 | 110.97 | 417,516 | |
11/04/2024 | 112.13 | 113.98 | 107.19 | 108.97 | 767,498 | |
11/01/2024 | 113.32 | 113.76 | 109.58 | 111.48 | 984,807 | |
10/31/2024 | 112.80 | 113.43 | 110.20 | 113.10 | 704,344 | |
10/30/2024 | 112.61 | 114.57 | 110.90 | 113.94 | 844,267 | |
10/29/2024 | 114.24 | 115.80 | 113.47 | 114.01 | 684,945 | |
10/28/2024 | 110.54 | 113.75 | 110.27 | 113.26 | 666,765 | |
10/25/2024 | 111.50 | 112.14 | 109.86 | 110.48 | 531,127 | |
10/24/2024 | 110.75 | 113.34 | 110.75 | 111.73 | 611,384 | |
10/23/2024 | 111.00 | 111.64 | 109.81 | 110.98 | 454,093 | |
10/22/2024 | 111.13 | 111.89 | 109.59 | 110.88 | 561,570 | |
10/21/2024 | 111.58 | 112.01 | 108.86 | 111.58 | 712,202 | |
10/18/2024 | 113.57 | 114.22 | 108.75 | 111.77 | 1,320,094 | |
10/17/2024 | 117.30 | 117.64 | 114.37 | 114.47 | 709,256 | |
10/16/2024 | 117.64 | 118.40 | 116.50 | 117.74 | 471,114 | |
10/15/2024 | 118.97 | 119.86 | 116.60 | 117.53 | 611,707 | |
10/14/2024 | 119.68 | 121.57 | 119.67 | 120.14 | 548,468 | |
10/11/2024 | 118.19 | 120.91 | 117.46 | 120.52 | 472,558 | |
10/10/2024 | 117.48 | 118.53 | 115.77 | 118.37 | 489,063 | |
10/09/2024 | 119.28 | 119.45 | 116.72 | 117.47 | 597,792 | |
10/08/2024 | 120.45 | 122.47 | 120.12 | 120.30 | 524,679 | |
10/07/2024 | 122.19 | 124.00 | 119.88 | 121.55 | 901,583 | |
10/04/2024 | 119.70 | 124.14 | 119.68 | 122.68 | 679,982 | |
10/03/2024 | 118.80 | 120.09 | 117.94 | 119.80 | 946,192 | |
10/02/2024 | 118.92 | 120.30 | 115.16 | 119.00 | 776,379 | |
10/01/2024 | 119.91 | 120.76 | 117.67 | 119.93 | 750,335 | |
09/30/2024 | 117.30 | 119.20 | 116.91 | 118.77 | 577,709 | |
09/27/2024 | 119.17 | 119.31 | 117.30 | 118.22 | 525,610 | |
09/26/2024 | 116.81 | 118.00 | 115.21 | 117.64 | 653,286 | |
09/25/2024 | 117.71 | 119.75 | 115.33 | 115.80 | 903,082 | |
09/24/2024 | 116.79 | 119.60 | 115.00 | 118.47 | 1,698,081 | |
09/23/2024 | 113.47 | 114.13 | 111.00 | 113.05 | 1,163,966 | |
09/20/2024 | 111.43 | 114.33 | 110.47 | 112.28 | 1,523,900 | |
09/19/2024 | 117.18 | 117.28 | 110.34 | 112.51 | 1,981,736 | |
09/18/2024 | 121.40 | 122.99 | 115.50 | 115.62 | 1,966,668 | |
09/17/2024 | 127.40 | 131.49 | 121.88 | 124.71 | 2,562,050 | |
09/16/2024 | 121.77 | 129.38 | 120.94 | 123.47 | 3,837,042 | |
09/13/2024 | 105.08 | 125.41 | 105.00 | 123.40 | 6,296,278 | |
09/12/2024 | 97.00 | 105.07 | 95.45 | 105.00 | 1,839,233 | |
09/11/2024 | 100.99 | 101.66 | 97.33 | 99.27 | 925,102 | |
09/10/2024 | 96.38 | 103.19 | 96.38 | 100.63 | 1,703,521 | |
09/09/2024 | 91.33 | 101.15 | 90.92 | 100.53 | 2,369,711 | |
09/06/2024 | 89.40 | 90.39 | 88.30 | 89.94 | 654,870 | |
09/05/2024 | 88.84 | 91.68 | 88.84 | 90.15 | 556,384 |
About BioNTech Stock history
BioNTech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for BioNTech is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in BioNTech SE will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing BioNTech stock prices may prove useful in developing a viable investing in BioNTech
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 242.7 M | 229.1 M | |
Net Income Applicable To Common Shares | 11.8 B | 12.4 B |
BioNTech Quarterly Net Working Capital |
|
BioNTech Stock Technical Analysis
BioNTech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Equity Analysis Now
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
All Next | Launch Module |
BioNTech Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for BioNTech's price direction in advance. Along with the technical and fundamental analysis of BioNTech Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of BioNTech to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.1137 | |||
Jensen Alpha | 0.3638 | |||
Total Risk Alpha | (0.12) | |||
Sortino Ratio | 0.14 | |||
Treynor Ratio | 0.4649 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for BioNTech Stock Analysis
When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.